Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

Circulation

Volumn 97, Issue 12, 1998, Pages 1114-1123

  Baumgartner, Iris ^a   Pieczek, Ann ^a   Manor, Orit ^a   Blair, Richard ^a   Kearney, Marianne ^a   Walsh, Kenneth ^a   Isner, Jeffrey M ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Genes; Growth substances; Ischemia

Indexed keywords

PLASMID DNA; VASCULOTROPIN; DNA; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; VASCULOTROPIN A;

ADULT; AGED; ANGIOGENESIS; ANGIOGRAPHY; ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; COLLATERAL CIRCULATION; EDEMA; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; LIMB ISCHEMIA; LIMB PERFUSION; LIMB SALVAGE; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SYMPTOMATOLOGY; TREATMENT OUTCOME; AMPUTATION; CHEMISTRY; GENETICS; IMMUNOHISTOCHEMISTRY; INTRAMUSCULAR DRUG ADMINISTRATION; ISCHEMIA; LIMB; MIDDLE AGED; PAIN ASSESSMENT; PLASMID; SKELETAL MUSCLE; TRANSGENE; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; ANGIOGRAPHY; COLLATERAL CIRCULATION; DNA; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; EXTREMITIES; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAMUSCULAR; ISCHEMIA; LYMPHOKINES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PAIN MEASUREMENT; PLASMIDS; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032583951     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.12.1114     Document Type: Article

References (59)

1. European Working Group on Critical Leg Ischemia Second European consensus document on chronic critical leg ischemia. Circulation. 1991: 84(suppl IV):IV-1-IV-26.
2. Dormandy J, Mahir M, Ascady G, Balsano F, De Leeuw P, Blombery P, Bousser MG, Clement D, Coffman J, Deutschinoff A, Bletry O, Hampton J, Hahler F, Ohlin P, Rieger H, Stranden E, Turpie AGG, Urai L, Verstraete M. Fate of the patient with chronic leg ischaemia. J Cardiovasc Surg. 1989;1:50-57.
3. Rutherford RB, Flanigan DP, Gupta SK, Johnston KW, Karmondy A, Whittemore AD, Baker D, Ernst CB, Jamieson C, Mehta S. Suggested standards for reports dealing with lower extremity ischemia. Ad Hoc Committee on Reporting Standards. Society for Vascular Surgery/North American Chapter. International Society for Cardiovascular Surgery. J Vasc Surg. 1986;4:80-94.
4. Albers M, Fratezi AC, DeLuccia N. Assessment of quality of life of patients with severe ischemia as a result of infrainguinal arterial occlusive disease. J Vasc Surg. 1992;16:54-59.
5. Isner JM, Rosenfield K. Redefining the treatment of peripheral artery disease. Circulation. 1993;88:1534-1557.
6. Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care. 1983;6:87-91.
7. Taylor LM Jr, Porter JM. Natural history and non-operative treatment of chronic lower extremity ischemia. In: Rutherford RB, ed. Vascular Surgery. Philadelphia, Pa: WB Saunders; 1989:656.
8. Wolfe JHN. Defining the outcome of critical ischemia: a one year prospective study. Br J Surg. 1986;73:321-328.
9. Eneroth M, Persson BM. Amputation for occlusive arterial disease: a multicenter study of 177 amputees. Int Orthop. 1992;16:382-387.
10. Campbell WB, Johnston JA, Kernick VF, Rutter EA. Lower limb amputation: striking the balance. Ann R Coll Surg Engl. 1994;76:205-209.
11. Dawson I, Keller BP, Brand R, Pesch-Batenburg J, Hajo van Bockel J. Late outcomes of limb loss after failed infrainguinal bypass. J Vasc Surg. 1995;21:613-622.
12. Skinner JA, Cohen AT. Amputation for premature peripheral atherosclerosis: do young patients do better? Lancet. 1996;348:1396.
13. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg. 1992;16:181-191.
14. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest. 1994;93:662-670.
15. Hariawala M, Horowitz JR, Esakof D, Sheriff DD, Walter DH, Chaudhry GM, Desai V, Keyt B, Isner JM, Symes JF, VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res. 1996;63:77-82.
16. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994;89:2183-2189.
17. Pearlman JD, Hibberd MG, Chuang ML, Harada K, Lopez JJ, Gladston SR, Friedman M, Sellke FW, Simons M. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med. 1995;1:1085-1089.
18. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219:983-985.
19. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
20. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 1989;246:1309-1312.
21. Plouet J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J. 1989;8:3801-3806.
22. Ferrera N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989;161:851-855.
23. D'Amore PA, Thompson RW. Mechanisms of angiogenesis. Annu Rev Physiol. 1987;49:453-464.
24. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931-10934.
25. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671-674.
26. 165. Lancet. 1996;348:370-374.
27. Standards of Practice Committee of the Society of Cardiovascular and Interventional Radiology. Guidelines for percutaneous transluminal angioplasty. J Vasc Interv Radiol. 1990;1:5-13.
28. Rutherford RB, Becker GJ. Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease. Radiology. 1991;181:277-281.
29. Tischer E, Mitchell R, Hartmann T, Silva M, Gospodarowicz D, Fiddes J, Abraham J. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J Biol Chem. 1991;266:11947-11954.
30. Summer DS, Thiele BI. The vascular laboratory. In: Rutherford RB, ed. Vascular Surgery. Philadelphia. Pa: WB Saunders; 1995:45-64.
31. Owen RS, Carpenter JP, Baum RA, Perloff LJ, Cope C. Magnetic resonance imaging of angiographically occult runoff vessels in peripheral arterial occlusive disease. N Engl J Med. 1992;326:1577-1581.
32. Couffinhal T, Kearney M, Witzenbichler B, Chen D, Murohara T, Losordo DW, Symes JF, Isner JM. Vascular endothelial growth factor/ vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol. 1997;150:1673-1685.
33. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Theme H, Iwamoto MA, Parke JE, Nguyen MD, Aiello LM, Ferrara N, King GL. Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
34. Ferrara N, Winer J, Burton T, Rowland A, Siegel M, Phillips HS, Terrell T, Keller GA, Levinson AD. Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest. 1992;91:160-170.
35. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146:1029-1039.
36. Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP, and the Vascular Clinical Trialists. Clinical trials for claudication assessment of exercise performance, functional status, and clinical end points. Circulation. 1995;92:614-621.
37. Schaper W, Brahander MD, Lewi P. DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res. 1971;28:671-679.
38. Takeshita S, Isshiki T, Tanaka E, Eto K, Miyazawa Y, Tanaka A, Shinozaki Y, Hyodo K, Ando M, Kubota M, Tanioka K, Umetani K, Ochiai M, Sato T, Mori H, Miyashita H. Use of synchrotron radiation microangiography to assess development of small collateral arteries in a rat model of hindlimb ischemia. Circulation. 1997;95:805-808.
39. Wolff JA, Malone Rw, Williams P, Chong W, Acsadi G, Jani A, Felgner PL. Direct gene transfer into mouse muscle in vivo. Science. 1990;247:- 1465-1468.
40. Takeshita S, Isshiki T, Sato T. Increased expression of direct gene transfer into skeletal muscles observed after acute ischemic injury in rats. Lab Invest. 1996;74:1061-1065.
41. Stratford-Perricaudet LD, Makeh I. Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest. 1992;90:626-630.
42. Manthorpe M, Cornefert-Jensen F, Hartikka J, Felgner J. Rundell A, Margalith M, Dwarki v. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum Gene Ther. 1993;4:419-431.
43. Davis HL, Whalen RG, Demeneix BA. Direct gene transfer into skeletal muscle in vivo. Hum Gene Ther. 1993;4:151-159.
44. Vitadello M, Schiaffino M, Picard A, Scarpa M, Schiaffino S. Gene transfer in regenerating muscle. Hum Gene Ther. 1994;5:11-18.
45. Levy MY, Barron LG, Meyer KB, Szoka FC. Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood. Gene Ther. 1996;3:201-211.
46. Tsurumi Y, Takeshita S, Chen D, Kearney M, Rossow ST, Passeri J, Horowitz JR, Symes JF. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation. 1996;94:3281-3290.
47. Tripathy SK, Svensson EC, Black HB, Goldwasser E, Margalith M, Hobart PM, Leiden JM. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc Natl Acad Sci U S A. 1996;93:10876-10880.
48. Hartikka J, Sawdey M, Cornefert-Jensen F, Margalith M, Barnhart K, Nolasco M, Vahlsing L, Meek J, Marquet M, Hobart P, Norman J, Manthorpe M. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum Gene Ther. 1996;7:1205-1217.
49. Takeshita S, Tsurumi Y, Couffinhal T, Asahara T, Bauters C, Symes JF, Ferrara N, Isner JM. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest. 1996;75:487-502.
50. Takeshita S, Weir L, Chen D, Zheng LP, Riessen R, Bauters C, Symes JF, Ferrara N, Isnerr JM. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem Biophys Res Commun. 1996;227:628-635.
51. Verma IM, Somia N. Gene therapy: promises, problems, and prospects. Nature. 1997;389:239-242.
52. Losordo DW, Pickering JG, Takeshita S, Leclerc G, Gal D, Weir L, Kearney M, Jekanowski J, Isner JM. Use of the rabbit ear artery to serially assess foreign protein secretion after site specific arterial gene transfer in vivo: evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation. 1994;89:785-792.
53. Namiki A, Brogi E, Kearney M, Wu T, Couffinhal T. Varticovski L. Isner JM. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem. 1995;270;31189-31195.
54. Spryidoupoulos I, Borgi E, Kearney M, Sullivan AB, Cetrulo C, Isner JM, Losordo DW. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals. J Mol Cell Cardiol. 1997;29:1321-1330.
55. Sender DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Perruzi CA, Detmer M. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the avb3 integrin, osteopontin, and thrombin. Am J Pathol. 1996;149:293-305.
56. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM. Hypoxia-induced paracrine regulation of VEGF receptor expression J Clin Invest. 1996;97:469-476.
57. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182-1186.
58. Horowitz JR, Rivard A, van der Zee R, Hariawala MD, Sheriff DD. Esakof DD, Chaudhry M, Symes JF, Isner JM. Vascular endothelial growth factor/vascular permiability factor produces nitric oxide-dependent hypotension. Arterioscler Thromb Vasc Biol. 1997;17:2793-2800.
59. Leiden JM. Gene therapy promise, pitfalls, and prognosis. N Engl J Med. 1995;333:871-873.